Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study

Figure 3

Overall survival probability (Kaplan-Meyer) of pretreated patients with pseudomyxoma peritonei (PMP), malignant peritoneal mesothelioma (MESO), and peritoneal metastasis of colorectal (CRC), appendiceal (APP), ovarian (OV), hepatobiliary-pancreatic (HBP), and gastric (GC) origins. Survival calculated from the date of first PIPAC.